Correlation Between 4D Molecular and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Design Therapeutics, you can compare the effects of market volatilities on 4D Molecular and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Design Therapeutics.
Diversification Opportunities for 4D Molecular and Design Therapeutics
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between FDMT and Design is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of 4D Molecular i.e., 4D Molecular and Design Therapeutics go up and down completely randomly.
Pair Corralation between 4D Molecular and Design Therapeutics
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the Design Therapeutics. In addition to that, 4D Molecular is 1.08 times more volatile than Design Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. Design Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 786.00 in Design Therapeutics on August 30, 2024 and sell it today you would lose (189.00) from holding Design Therapeutics or give up 24.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. Design Therapeutics
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| Design Therapeutics |
4D Molecular and Design Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and Design Therapeutics
The main advantage of trading using opposite 4D Molecular and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.| 4D Molecular vs. Bright Minds Biosciences | 4D Molecular vs. HP Inc | 4D Molecular vs. Intel | 4D Molecular vs. Chevron Corp |
| Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |